A medical technology company using artificially powered intelligence and nano-technology to build revolutionary diagnostic equipment.
Burlington, ON
Joined November 2017
- Tweets5.1K
- Following3.4K
- Followers878
- Likes2.2K
Canary Global Inc. retweeted
BA.2.75.2 may be “a” concern, but it’s not “the” concern.
What is worrying is the trend that happened in the last few months in Omicron, and more robust in the polytomy of BA.2.75 - The RBD region, which was highly conserved in the past, shows increasing plasticity.
1/4
Canary Global Inc. retweeted
Looking forward to hosting Dr Lisa Newman @BrighamSurgery and @DFCI_BreastOnc for Carolyn Kaelin visiting Professorship.
Canary Global Inc. retweeted
Our chief fellow @Sunil_G_Iyer presenting important collaborative effort between @SylvesterCancer and @MSKCancerCenter to improve HCT utilization in racial minorities at the 15th. @AACR Conference on Cancer Care Disparities. #AACRdisp22 #bmtsm – at Miami Beach, FL
Canary Global Inc. retweeted
Published today: @TheLancet Commission on Covid-19:
"a massive global failures" with recommendations going forward
thelancet.com/commissions/co…
It's a 57-page paper. I think this Figure and the 1-pager editorial summarize it well
Canary Global Inc. retweeted
With #ESMO22 turning to history, on the plane back to 🇬🇷, Ι added a column of main outcomes/potential clinical relevance in my previous list of influential trials in #NSCLC
🙏@myESMO staff, officers,speakers,chairs, attendees for a magical experience!
@OncoAlert #some #LCSM
Canary Global Inc. retweeted
Day 4 #ESMO22 Highlights from #CommunityOncologists perspective:
1. #IFCT1701 - ICI in mNSCLC
2. #POSEIDON Update - mNSCLC @MLJohnsonMD2
3. #CodeBreak200 - KRAS G12C NSCLC @MLJohnsonMD2
#LCSM #MedTwitter #OncEd @HemOncFellows @OncoAlert @myESMO
1/9
Canary Global Inc. retweeted
Probably the most awaited trial #ESMO22. CODEBREAK200 (sotorasib vs doc in 2/3L NSCLC)
✅PFS HR 0.66 (5.6 vs 4.5 m / 24.8 vs 10.1% at 1 yr)
✅ORR 28.1 vs 10.2 %
❎OS HR 1.01
✅fewer gr. ≥3 & serious TRAEs
Endless discussion regarding the magnitude of benefit awaited @OncoAlert
Canary Global Inc. retweeted
Nivo IPI adjuvant RCC is negative. Larger than life @motzermd presenting! Standing room only. Is it tolerability that caused this? 57% completed all cycles. Sizeable pT2 group and no M1NED may have made the population less high risk. @OncoAlert @IMDConline @bmsnews
Canary Global Inc. retweeted
A patient presents with a distended abdomen. His eyes look like this. What’s the diagnosis?
#MedTwitter
Canary Global Inc. retweeted
Congratulations to @CharlesSwanton for an elegant answer to the question of LC causality in never smokers! Opening the possibility of LC prevention with IL 1b inh. Similarly to tobacco exposure, we should reduce PM2.5 air pollution exposure. @myESMO
Canary Global Inc. retweeted
#Lungcancer awareness month is November! Join us this #LCAM and show your support by either making or buying a white ribbon! Check out here for more white ribbon resources: bit.ly/3QpfvyD
Canary Global Inc. retweeted
Updated @NCCN guidelines recommends genetic testing in all women <50 yrs at breast ca dx.Our study in @JCO_ASCO ⬇️ has shown that this threshold will miss >10% of BRCA1/2 carriers.We need to expand testing to all women under 65 at breast ca dx to identify >95% of BRCA1/2 carriers
Canary Global Inc. retweeted
Dose matters !!! DESTINY-LUNG02 trial. Same efficacy, less toxicity including pneumonitis in HER2 mut #NSCLC with 5.4 vs 6.4 dose. Should be the standard dose. Please include patient in DESTINY-LUNG04 trial (exp arm dose is 5.4) #ESMO22 @OncoAlert
Canary Global Inc. retweeted
It wasn't an easy journey but I couldn't be more grateful.
A million thanks to all the friends and family who made it possible! and to @USJLiban @UWorldMedical @ambossmed
Excited for what the future holds!
@StoriesImg @IMG_Advocate @ImgJourney
